Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd banner

Intrinsic Value

The intrinsic value of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (2TZ) under the Base Case is 1.64 EUR per share. Compared with the current market price of 2.3 EUR, the stock appears Overvalued by 29% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

2TZ Intrinsic Value
€1.64
Overvaluation 29%
Intrinsic Value
Price €2.3
Alert me when 2TZ is below its intrinsic value
Today €1.31 · 43.1% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to 2TZ

Fundamental Analysis

What Tianjin Pharmaceutical Da Ren Tang Group Does

Pharmaceuticals Health Care

Tianjin Pharmaceutical Da Ren Tang Group makes and sells traditional Chinese medicines, prescription drugs, over-the-counter remedies, and related health products. Its core business is turning classic Da Ren Tang formulas into branded medicines that are sold through pharmacies, hospitals, distributors, and direct retail channels. The company earns money by manufacturing these products and selling them under its own brand.

Headquarters
China CN
Employees
3 890
IPO date
Jun 6, 2001
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 2TZ stock?

The intrinsic value for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (2TZ) under the Base Case is 1.64 EUR.

Is 2TZ stock undervalued or overvalued?

Compared with the current market price of 2.3 EUR, the stock appears Overvalued by 29% .

Back to Top